行业分析 |
|
|
|
|
美国生物医药产业竞争力分析与启示 |
尹政清1,*(),白京羽2,林晓锋2 |
1中国农业大学信息与电气工程学院 北京 100083 2国家发展和改革委员会创新驱动发展中心 北京 100037 |
|
Competitiveness Analysis and Enlightenment of Biomedical Industry in USA |
YIN Zheng-qing1,*(),BAI Jing-yu2,LIN Xiao-feng2 |
1 College of Information and Electrical Engineering, China Agricultural University, Beijing 100083,China 2 Innovation Driven Development Center, National Development and Reform Commission, Beijing 100037,China |
[1] |
石光, 刘芳瑜. 我国生物医药产业发展的现状与对策. 中国卫生政策研究, 2016,9(3):16-19.
|
|
Shi G, Liu F Y. The status quo and strategies on biotechnological medicine industry development in China. Chinese Journal of Health Policy, 2016,9(3):16-19.
|
[2] |
Morrison C. 2019 biotech IPOs: Party on. Nature Reviews Drug Discovery, 2020,49(1):6-9.
|
[3] |
郭中平. 生物药和生物类似药研究的现状与发展. 临床药物治疗杂志, 2020,18(5):1-6.
|
|
Guo Z P. Current situation and development in research on biotherapeutic and biosimilars. Clinical Medication Journal, 2020,18(5):1-6.
|
[4] |
Hodgson J. Biotech’s baby boom. Nature Biotechnology, 2019,37(5):502-512.
doi: 10.1038/s41587-019-0112-4
pmid: 31053818
|
[5] |
中华人民共和国科学技术部. 美国发布《国家生物经济蓝图》. [2020-06-14]. http://www.most.gov.cn/gnwkjdt/201206/t20120612_94963.htm.
|
|
Ministry of Science and Technology of the People’s Republic of China. . U.S. releases “National Bioeconomic Blueprint”. [2020-06-14]. http://www.most.gov.cn/gnwkjdt/201206/t20120612_94963.htm.
|
[6] |
中华人民共和国国务院. “十三五”国家科技创新规划. [2020-06-14]. http://www.gov.cn/zhengce/content/2016-08/08/content_5098072.htm.
|
|
State Council of the People’s Republic of China. National science and technology innovation plan of “the 13th Five-year Plan”. [2020-06-14]. http://www.gov.cn/zhengce/content/2016-08/08/content_5098072.htm.
|
[7] |
国家发展改革委. “十三五”生物产业发展规划. [2020-06-14]. https://www.ndrc.gov.cn/fggz/fzzlgh/gjjzxgh/201706/W020191104624250601539.pdf.
|
|
National Development and Reform Commission. Biological industry development plan of “the 13th Five-year Plan”. [2020-06-14]. https://www.ndrc.gov.cn/fggz/fzzlgh/gjjzxgh/201706/W020191104624250601539.pdf.
|
[8] |
钱景怡, 余正. 我国生物制药产业国际竞争力分析. 中国药事, 2020,34(5):549-555.
|
|
Qian J Y, Yu Z. On the international competitiveness of China’s bio-pharmaceutical industry. Chinese Pharmaceutical Affairs, 2020,34(5):549-555.
|
[9] |
Carlson R. Estimating the biotech sector’s contribution to the US economy. Nature Biotechnology, 2016,34(3):247-255.
pmid: 26963545
|
[10] |
张金昌. 国际竞争力评价的理论和方法研究. 北京: 中国社会科学院研究生院, 2001.
|
|
Zhang J C. Research on the theory and method of international competitiveness evaluation. Beijing: Graduate School of Chinese Academy of Social Sciences, 2001.
|
[11] |
Irfan M, Zhao Z Y, Ahmad M, et al. Critical factors influencing wind power industry: A Diamond Model based study of India. Energy Reports, 2019,5(1):1222-1235.
|
[12] |
Fang K, Zhou Y H, Wang S, et al. Assessing national renewable energy competitiveness of the G20: A revised Porter’s Diamond Model. Renewable and Sustainable Energy Reviews, 2018,93(1):719-731.
|
[13] |
Chung T W. A study on logistics cluster competitiveness among Asia main countries using the Porter’s Diamond Model. The Asian Journal of Shipping and Logistics, 2016,32(4):257-264.
|
[14] |
Özer K O, Latif H, Sariisik M, et al. International competitive advantage of Turkish tourism industry: A comperative analyse of Turkey and Spain by using the Diamond Model of M. Porter. Procedia - Social and Behavioral Sciences, 2012,58(1):1064-1076.
|
[15] |
迈克尔·波特. 国家竞争优势. 北京: 华夏出版社, 2002: 123-136.
|
|
Michael E P. Competitive advantage of nations. Beijing: Huaxia Publishing House, 2002: 123-136.
|
[16] |
纪蕾, 李红艳, 王颖, 等. 基于钻石模型的山东省海洋生物医药产业竞争力分析. 渔业研究, 2019,41(5):430-440.
|
|
Ji L, Li H Y, Wang Y, et al. Research on the competitiveness of marine bio pharmaceutical industry in Shandong Province based on diamond model. Journal of Fisheries Research, 2019,41(5):430-440.
|
[17] |
赵冰, 张东生, 赵拥政. 区域生物医药产业基于钻石模型的竞争力研究:以石家庄为例. 中国生物工程杂志, 2011,31(9):140-145.
|
|
Zhao B, Zhang D S, Zhao Y Z. Research on the competitiveness of regional biomedical industry:Taking Shijiazhuang as example. China Biotechnology, 2011,31(9):140-145.
|
[18] |
Clarivate Analytics. Web of Science. [2020-06-14]. https://webofknowledge.com.
pmid: 26293960
|
[19] |
朱修篁, 易香华, 薛芳芳, 等. 生物医药专利分布及趋势研究. 中国新药杂志, 2015,24(15):1686-1693.
|
|
Zhu X H, Yi X H, Xue F F, et al. Investigation and analysis of healthcare patents distribution and trend. Chinese Journal of New Drugs, 2015,24(15):1686-1693.
|
[20] |
国家药品监督管理局. 全球药物研发数据库. [2020-06-10]. https://shuju.menet.com.cn.
|
|
National Medical Products Administration. Global drug R&D database. [2020-06-10]. https://shuju.menet.com.cn.
|
[21] |
Crunchbase. Crunchbase. [2020-03-31]. https://www.crunchbase.com.
|
[22] |
Graul A I, Pina P, Cruces E, et al. 2018年全球新药研发报告第1部分:新药和生物制剂(Ⅰ). 药学进展, 2019,41(4):309-317.
|
|
Graul A I, Pina P, Cruces E, et al. A report of new drugs research and development in 2018 Part I: New drugs & biologies (Ⅰ). Progress in Pharmaceutical Sciences, 2019,41(4):309-317.
|
[23] |
Hernández H, Grassano N, Tübke A, et al. The 2019 EU industrial R&D investment scoreboard. Luxembourg: Publications Office of the European Union, 2019: 62.
|
[24] |
Fast Company. The world’s 50 most innovative companies 2019. [2020-06-14]. https://www.fastcompany.com/most-innovative-companies/2019/sectors/biotech.
|
[25] |
Fast Company. The world’s 50 most innovative companies 2018.[2020-06-14]. https://www.fastcompany.com/most-innovative-companies/2018/sectors/biotech.
|
[26] |
Genetic Engineering and Biotechnology News. Top 25 biotech companies of 2019. [2020-06-14]. https://www.genengnews.com/a-lists/top-25-biotech-companies-of-2019.
|
[27] |
Quacquarelli Symonds. The QS World University Rankings. [2020-06-14] https://www.topuniversities.com/university-rankings/university-subject-rankings/2020/biological-sciences.
|
[28] |
Lindburg L, Bozinovic L, Susek R. As the life science industry evolves, so do its talent needs. Nature Biotechnology, 2019,37(4):481-483.
pmid: 30940939
|
[29] |
黄玮. 生物医药产业风险投资模式研究. 上海: 复旦大学, 2006.
|
|
Huang W. Research on venture capital model of biomedical industry. Shanghai: Fudan University, 2006.
|
[30] |
张佳睿. 美国生物医药产业发展的经验及启示. 商业研究, 2015,39(12):24-28.
|
|
Zhang J R. Development experience of American biomedical industry and its enlightenment. Commercial Research, 2015,39(12):24-28.
|
[31] |
火石创造. 2019年全球生物医药领域十大风险投资事件. [2020-06-14]. https://med.sina.com/article_detail_103_2_76424.html.
|
|
Hsmap. Top 10 venture capital events in global biomedical field in 2019. [2020-06-14]. https://med.sina.com/article_detail_103_2_76424.html.
|
[32] |
Ernst & Young. Beyond borders staying the course: Biotechnology report 2017. [2020-06-17]. http://www.ey.com/Publication/vwLUAssets/ey-biotechnology-report-2017-beyond-borders-staying-the-course/%24FILE/ey-biotechnology-report-2017-beyond-borders-staying-the-course.pdf.
|
[33] |
郑晓奋. 美国生物技术产业集群创新及对我国的启示. 海南大学学报(人文社会科学版), 2011,29(3):50-54.
|
|
Zheng X F. The cluster innovation of American biotechnology industry and its enlightenment to China. Humanities & Social Sciences Journal of Hainan University, 2011,29(3):50-54.
|
[34] |
张擎. 美国生物医药产业园区发展特点及启示. 中国高新区, 2011,11(4):111-113.
|
|
Zhang Q. Development characteristics and enlightenment of biomedical industrial park in the United States. Science & Technology Industry Parks, 2011,11(4):111-113.
|
[35] |
JPMorgan. J. P. 2020 US Biotech Outlook. 38th Annual J.P. Morgan Healthcare Conference. San Francisco: JPMorgan, 2020: 73.
|
[36] |
HBM Partners. HBM Pharma/Biotech M&A Report 2020 . [2020-06-14]. https://hbmpartners.com/media/docs/industry-reports/HBM-Pharma-Biotech-M-A-Report-2020.pdf.
|
[37] |
Chen H M, Engkvist O, Wang Y H, et al. The rise of deep learning in drug discovery. Drug Discovery Today, 2018,23(6):1241-1250.
doi: 10.1016/j.drudis.2018.01.039
pmid: 29366762
|
[38] |
Zhang L, Tan J J, Han D, et al. From machine learning to deep learning: progress in machine intelligence for rational drug discovery. Drug Discovery Today, 2017,22(11):1680-1685.
pmid: 28881183
|
[39] |
王秀梅. 生物材料. 新型工业化, 2015,5(12):37-68.
|
|
Wang X M. Biological material. The Journal of New Industrialization, 2015,5(12):37-68.
|
[40] |
UN Comtrade. Commodity Trade Statistics Database. [2020-06-14]. https://comtrade.un.org.
|
[41] |
World Bank. World Development Indicators.[ [2020-06-14]. http://databank.worldbank.org/data.
|
[42] |
姚恒美. 美国生物医药产业发展态势. [2020-06-14]. http://www.istis.sh.cn/list/list.aspx?id=12372.
|
|
Yao H M. . Development trend of biomedical industry in the United States. [2020-06-14]. http://www.istis.sh.cn/list/list.aspx?id=12372.
|
[43] |
王飞. 美国生物医药产业创新的升级规律及启示. 南京社会科学, 2019,30(8):29-35.
|
|
Wang F. Upgrading law and enlightenment of biomedical industry innovation in USA. Nanjing Journal of Social Sciences, 2019,30(8):29-35.
|
[44] |
朱信凯, 涂圣伟, 杨顺江. 国际生物技术产业政策评论及对我国的启示. 中国软科学, 2005,20(11):18-23,76.
|
|
Zhu X K, Tu S W, Yang S J. Comment on the international biotechnology industry policy and the revelation for our country.
|
[45] |
中华人民共和国中央人民政府. 新型冠状病毒感染的肺炎诊疗方案(试行第三版). [2020-03-30]. http://www.gov.cn/zhengce/zhengceku/2020-01/23/5471832/files/106d59e45ac948ceb3cb12d400b8053c.pdf.
|
|
The Central People’s Government of the People’s Republic of China. Diagnosis and treatment of COVID-19 (trial version third). [2020-03-30]. http://www.gov.cn/zhengce/zhengceku/2020-01/23/5471832/files/106d59e45ac948ceb3cb12d400b8053c.pdf.
|
[46] |
Ledford H. The coronavirus outbreak could make it quicker and easier to trial drugs. Nature, 2020,582(1):172.
|
[47] |
Hodgson J. The pandemic pipeline. Nature Biotechnology, 2020,38(5):523-532.
pmid: 32203293
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|